Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in MYGN — Myriad Genetics Inc

CIK 1423053 MIAMI, FL
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$8,757,335
+$6,718,647 QoQ
Shares Held
1,533,684
+238.5% QoQ
Ownership
1.60%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 196 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Derivatives in MYGN

reported options exposure · as of Jun 30, 2026
CallValue
$184,433
CallShares
32,300
PutValue
$114,200
PutShares
20,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,695,016,013 across 33 Diagnostics & Research names. MYGN ranks #18 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 574,992 $288,277,988
2 CRL
Charles River Laboratories International, Inc.
 1,193,601 $270,696,770
3 GH
Guardant Health, Inc.
 1,449,534 $217,473,585
4 DHR
Danaher Corp /De/
 943,694 $179,754,833
5 RVTY
Revvity, Inc.
 1,457,335 $162,143,091
6 A
Agilent Technologies, Inc.
 1,101,501 $146,312,377
7 NTRA
Natera, Inc.
 265,607 $72,099,020
8 WGS
GeneDx Holdings Corp.
 865,462 $59,413,965

All Filings in MYGN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $184,433 32,300
2026-06-30 $114,200 20,000
2026-06-30 $8,757,335 1,533,684
2026-03-31 $76,950 17,100
2026-03-31 $2,038,688 453,042
2026-03-31 $93,150 20,700
2025-12-31 $1,677,541 272,771
2025-12-31 $107,010 17,400
2025-09-30 $135,924 18,800
2025-09-30 $4,136,643 572,150
2025-09-30 $432,354 59,800
2025-06-30 $75,402 14,200
2025-06-30 $132,219 24,900
2025-06-30 $9,085,521 1,711,021
2025-03-31 $136,598 15,400
2025-03-31 $4,746,611 535,131
2025-03-31 $161,434 18,200
2024-12-31 $10,491,453 765,241
2024-12-31 $283,797 20,700
2024-12-31 $212,505 15,500
2024-09-30 $884,697 32,300
2024-09-30 $1,864,190 68,061
2024-09-30 $495,759 18,100
2024-06-30 $533,228 21,800
2024-06-30 $43,148,662 1,764,050
2024-06-30 $362,008 14,800
2024-03-31 $304,876 14,300
2024-03-31 $29,134,781 1,366,547
2024-03-31 $550,056 25,800
2023-12-31 $543,576 28,400
2023-12-31 $453,618 23,700
2023-12-31 $22,280,529 1,164,082
2023-09-30 $208,520 13,000
2023-09-30 $10,798,833 673,244
2023-09-30 $742,652 46,300
2023-06-30 $875,577 37,773
2023-06-30 $208,620 9,000
2023-06-30 $375,516 16,200
2023-03-31 $69,690 3,000
2023-03-31 $49,828 2,145
2023-03-31 $1,739,927 74,900
2022-12-31 $976,523 67,300
2022-12-31 $481,688 33,197
2022-12-31 $40,628 2,800
2022-09-30 $518,976 27,200
2022-06-30 $423,361 23,300
2022-06-30 $755,872 41,600
2022-03-31 $786,240 31,200
2022-03-31 $1,207,080 47,900
2022-03-31 $1,084,154 43,022